H-FABP is an early marker of acute cardiac syndrome. When used together with other cardiac biomarkers – mainly cardiac troponins and natriuretic peptides – it can provide valuable additional information to support the diagnosis of patients with chest pain.
H-FABP is applied in emergency triage of patients with acute coronary syndromes. It could be used to identify patients with a low risk of AMI and consequently accelerate their discharge from hospital. In addition, H-FABP has been identified as a biomarker that is useful in regard to the prediction of adverse prognosis in patients with pulmonary embolism.
H-FABP alone is not specific enough as a marker for cardiac injuries since it is expressed also in other tissues than heart. However, as part of a multi-marker panel H-FABP brings additional value in supporting clinical diagnostics decisions.
Heart type fatty acid binding protein TechNotes
4F29 Fatty Acid Binding Protein (FABP) antibody
8F65 Fatty Acid Binding Protein (FABP)
8FFS FABP (Fatty Acid Binding Protein) free serum
See other Cardiac markers